20 reports of this reaction
1.9% of all POTASSIUM NITRATE AND SODIUM FLUORIDE reports
#12 most reported adverse reaction
DRUG EFFECTIVE FOR UNAPPROVED INDICATION is the #12 most commonly reported adverse reaction for POTASSIUM NITRATE AND SODIUM FLUORIDE, manufactured by Haleon US Holdings LLC. There are 20 FDA adverse event reports linking POTASSIUM NITRATE AND SODIUM FLUORIDE to DRUG EFFECTIVE FOR UNAPPROVED INDICATION. This represents approximately 1.9% of all 1,057 adverse event reports for this drug.
Patients taking POTASSIUM NITRATE AND SODIUM FLUORIDE who experience drug effective for unapproved indication should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG EFFECTIVE FOR UNAPPROVED INDICATION is a less commonly reported adverse event for POTASSIUM NITRATE AND SODIUM FLUORIDE, but still significant enough to appear in the safety profile.
In addition to drug effective for unapproved indication, the following adverse reactions have been reported for POTASSIUM NITRATE AND SODIUM FLUORIDE:
The following drugs have also been linked to drug effective for unapproved indication in FDA adverse event reports:
DRUG EFFECTIVE FOR UNAPPROVED INDICATION has been reported as an adverse event in 20 FDA reports for POTASSIUM NITRATE AND SODIUM FLUORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG EFFECTIVE FOR UNAPPROVED INDICATION accounts for approximately 1.9% of all adverse event reports for POTASSIUM NITRATE AND SODIUM FLUORIDE, making it a notable side effect.
If you experience drug effective for unapproved indication while taking POTASSIUM NITRATE AND SODIUM FLUORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.